119 related articles for article (PubMed ID: 22180371)
1. Omeprazole does not change the oral bioavailability or pharmacokinetics of vinpocetine in rats.
Sozański T; Magdalan J; Trocha M; Szumny A; Merwid-Ląd A; Słupski W; Karaźniewicz-Łada M; Kiełbowicz G; Ksiądzyna D; Szeląg A
Pharmacol Rep; 2011; 63(5):1258-63. PubMed ID: 22180371
[TBL] [Abstract][Full Text] [Related]
2. Study on the absorption of vinpocetine and apovincaminic acid.
Pudleiner P; Vereczkey L
Eur J Drug Metab Pharmacokinet; 1993; 18(4):317-21. PubMed ID: 8020528
[TBL] [Abstract][Full Text] [Related]
3. Optimized preparation of vinpocetine proliposomes by a novel method and in vivo evaluation of its pharmacokinetics in New Zealand rabbits.
Xu H; He L; Nie S; Guan J; Zhang X; Yang X; Pan W
J Control Release; 2009 Nov; 140(1):61-8. PubMed ID: 19651165
[TBL] [Abstract][Full Text] [Related]
4. Optimized preparation of in situ forming microparticles for the parenteral delivery of vinpocetine.
Li J; Chen F; Hu C; He L; Yan K; Zhou L; Pan W
Chem Pharm Bull (Tokyo); 2008 Jun; 56(6):796-801. PubMed ID: 18520083
[TBL] [Abstract][Full Text] [Related]
5. Lack of pharmacokinetic interaction between vinpocetine and oxazepam.
Storm G; Oosterhuis B; Sollie FA; Visscher HW; Sommer W; Beitinger H; Jonkman JH
Br J Clin Pharmacol; 1994 Aug; 38(2):143-6. PubMed ID: 7981015
[TBL] [Abstract][Full Text] [Related]
6. [Pharmacokinetics and disposition of vinpocetine in rats].
Yao JH; Su CY; Chu XY
Yao Xue Xue Bao; 1994; 29(2):81-5. PubMed ID: 8042515
[TBL] [Abstract][Full Text] [Related]
7. Pharmacokinetics of apovincaminic acid in dogs.
Vereczkey L; Pudleiner P
Pol J Pharmacol Pharm; 1987; 39(2):161-5. PubMed ID: 3432163
[TBL] [Abstract][Full Text] [Related]
8. Effect of a proton pump inhibitor on the pharmacokinetics of imatinib.
Egorin MJ; Shah DD; Christner SM; Yerk MA; Komazec KA; Appleman LR; Redner RL; Miller BM; Beumer JH
Br J Clin Pharmacol; 2009 Sep; 68(3):370-4. PubMed ID: 19740393
[TBL] [Abstract][Full Text] [Related]
9. A randomized study investigating the effect of omeprazole on the pharmacokinetics of oral semaglutide.
Bækdal TA; Breitschaft A; Navarria A; Hansen CW
Expert Opin Drug Metab Toxicol; 2018 Aug; 14(8):869-877. PubMed ID: 29897249
[TBL] [Abstract][Full Text] [Related]
10. Pharmacokinetics of vinpocetine and its main metabolite apovincaminic acid before and after the chronic oral administration of vinpocetine to humans.
Miskolczi P; Kozma K; Polgár M; Vereczkey L
Eur J Drug Metab Pharmacokinet; 1990; 15(1):1-5. PubMed ID: 2384112
[TBL] [Abstract][Full Text] [Related]
11. Pharmacokinetics and comparative bioavailability of two vinpocetine tablet formulations in healthy volunteers by using the metabolite apovincaminic acid as pharmacokinetic parameter.
Vlase L; Bodiu B; Leucuta SE
Arzneimittelforschung; 2005; 55(11):664-8. PubMed ID: 16366040
[TBL] [Abstract][Full Text] [Related]
12. Effect of different doses of borneol on the pharmacokinetics of vinpocetine in rat plasma and brain after intraocular administration.
Ma Q; Dai M; Zhang H; Bai L; He N
Xenobiotica; 2020 May; 50(5):580-587. PubMed ID: 31424307
[TBL] [Abstract][Full Text] [Related]
13. A Phase 1 Pharmacokinetic Study of Cysteamine Bitartrate Delayed-Release Capsules Following Oral Administration with Orange Juice, Water, or Omeprazole in Cystinosis.
Armas D; Holt RJ; Confer NF; Checani GC; Obaidi M; Xie Y; Brannagan M
Adv Ther; 2018 Feb; 35(2):199-209. PubMed ID: 29411268
[TBL] [Abstract][Full Text] [Related]
14. Vinpocetine pharmacokinetics in elderly subjects.
Grandt R; Beitinger H; Schaltenbrand R; Braun W
Arzneimittelforschung; 1989 Dec; 39(12):1599-602. PubMed ID: 2624613
[TBL] [Abstract][Full Text] [Related]
15. In vitro-in vivo correlation of the pharmacokinetics of vinpocetine.
Szakács T; Veres Z; Vereczkey L
Pol J Pharmacol; 2001; 53(6):623-8. PubMed ID: 11985336
[TBL] [Abstract][Full Text] [Related]
16. Effect of age on the pharmacokinetics of vinpocetine (Cavinton) and apovincaminic acid.
Miskolczi P; Vereczkey L; Szalay L; Göndöc C
Eur J Clin Pharmacol; 1987; 33(2):185-9. PubMed ID: 3691609
[TBL] [Abstract][Full Text] [Related]
17. Effect of omeprazole on the pharmacokinetics of paricalcitol in healthy subjects.
Palaparthy R; Pradhan RS; Chan J; Rieser M; Chira T; Galitz L; Awni W; Williams LA
Biopharm Drug Dispos; 2007 Mar; 28(2):65-71. PubMed ID: 17173278
[TBL] [Abstract][Full Text] [Related]
18. Cyclodextrin multicomponent complexation and controlled release delivery strategies to optimize the oral bioavailability of vinpocetine.
Ribeiro LS; Falcão AC; Patrício JA; Ferreira DC; Veiga FJ
J Pharm Sci; 2007 Aug; 96(8):2018-28. PubMed ID: 17530626
[TBL] [Abstract][Full Text] [Related]
19. Effect of multiple doses of omeprazole on the pharmacokinetics, pharmacodynamics, and safety of a single dose of rivaroxaban.
Moore KT; Plotnikov AN; Thyssen A; Vaccaro N; Ariyawansa J; Burton PB
J Cardiovasc Pharmacol; 2011 Dec; 58(6):581-8. PubMed ID: 21822144
[TBL] [Abstract][Full Text] [Related]
20. Effect of soybean administration on the pharmacokinetics of carbamazepine and omeprazole in rats.
Singh D; Asad M
Fundam Clin Pharmacol; 2010 Jun; 24(3):351-5. PubMed ID: 19682087
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
